Aidapak Recalls Levothyroxine Sodium Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling Levothyroxine Sodium tablets because they may have been mislabeled as other prescription drugs.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences. The hazard is a labeling error (label mixup) rather than a contamination or structural defect, and no illnesses or injuries are reported in the source text.
Plain-English summary
Aidapak Services, LLC is recalling Levothyroxine Sodium, Tablet, 12.5 mcg (1/2 of 25 mcg), NDC 00527134101. The recall was initiated because the medication may have been mislabeled as other prescription drugs, including Calcium Acetate, Carbamazepine ER, or Chlorthalidone.
The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington. The recall involves specific pedigree codes and expiration dates, including AD30140_40 (EXP: 5/7/2014), AD46265_40 (EXP: 5/15/2014), and AD73525_49 (EXP: 5/30/2014).
Consumers and healthcare providers should check their inventory for these specific NDC and pedigree codes. If the medication is found, it should be returned to the distributor or disposed of according to local regulations. Patients should consult their healthcare provider if they have questions about their medication.
The recalled product
- Product
- LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00527134101.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- LEVOTHYROXINE SODIUM
- Tablet
- 12.5 mcg (1/2 of 25 mcg) has the following codes: Pedigree: AD30140_40
- EXP: 5/7/2014
- Pedigree: AD46265_40
- EXP: 5/15/2014
- Pedigree: AD73525_49
- EXP: 5/30/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateLiothyronine Sodium Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Tramadol Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Docusate Sodium Capsules Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Metoprolol Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Losartan Potassium Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- HighLiothyronine Sodium Tablets Recalled for Potential Labeling Errors
FDA (Drugs) · 2014-01-22